Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Bertalan Németh, Wim Goettsch, Finn Børlum Kristensen, Oresta Piniazhko, Mirjana Huić, Tomáš Tesař, Dragana Atanasijevic, Iga Lipska & Zoltán Kaló. (2020) The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries. Expert Review of Pharmacoeconomics & Outcomes Research 20:4, pages 321-330.
Read now
Read now
András Inotai & Bertalan Németh. (2019) Navigating joint HTA, procurement, and fair pricing: evidence-based insights and practical recommendations - A meeting report from ISPOR regional conference in Warsaw, 2019. Expert Review of Pharmacoeconomics & Outcomes Research 19:4, pages 379-381.
Read now
Read now
András Inotai, Huong Thanh Nguyen, Budi Hidayat, Talgat Nurgozhin, Pham Huy Tuan Kiet, Jonathan D. Campbell, Bertalan Németh, Nikos Maniadakis, Diana Brixner, Kalman Wijaya & Zoltán Kaló. (2018) Guidance toward the implementation of multicriteria decision analysis framework in developing countries. Expert Review of Pharmacoeconomics & Outcomes Research 18:6, pages 585-592.
Read now
Read now
Articles from other publishers (6)
Jing Yang, Yalin Jiang, Hongan Chen & Shengdao Gan. (2022) Digital finance and Chinese corporate labor investment efficiency: The perspective of financing constraints and human capital structure. Frontiers in Psychology 13.
Crossref
Crossref
András Inotai, Dominik Tomek, Maciej Niewada, László Lorenzovici, Martin Kolek, Jakub Weber, Anne-Katrin Kurrat, Emese Virág Kiss & Zoltán Kaló. (2020) Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries. Frontiers in Pharmacology 11.
Crossref
Crossref
Andras Inotai, Marcell Csanadi, Guenka Petrova, Maria Dimitrova, Tomasz Bochenek, Tomas Tesar, Kristina York, Leos Fuksa, Alexander Kostyuk, Laszlo Lorenzovici, Vitaly Omelyanovskiy, Katalin Egyed & Zoltan Kalo. (2018) Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts. BioMed Research International 2018, pages 1-9.
Crossref
Crossref
Péter Elek, Eszter Takács, Gergő Merész & Zoltán Kaló. (2016) Implication of external price referencing and parallel trade on pharmaceutical expenditure: indirect evidence from lower-income European countries. Health Policy and Planning, pages czw133.
Crossref
Crossref
Albena Zlatareva, Konstantin Tachkov, Milena Stoicheva, Svetla Georgieva, Maria Krasteva Bozhkova & Guenka Petrova. (2014) Modelling the Financial Framework of the Pharmacotherapy Cost of Rare Diseases with Orphan Medicines—Part II. Modern Economy 05:05, pages 499-505.
Crossref
Crossref
Albena Zlatareva, Konstantin Tachkov, Milena Stoicheva, Svetla Georgieva, Georgi Momekov & Guenka Petrova. (2014) Financial Analysis of the Access to Pharmacotherapy for Rare Diseases in Bulgaria. Modern Economy 05:05, pages 461-467.
Crossref
Crossref